MORGAN STANLEY - FENNEC PHARMACEUTICALS INC ownership

FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 30 filers reported holding FENNEC PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.60 and the average weighting 0.4%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of FENNEC PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$318,875
-40.5%
42,460
-30.0%
0.00%
Q2 2023$535,609
+10.7%
60,658
+4.3%
0.00%
Q1 2023$484,000
+11.1%
58,173
+28.2%
0.00%
Q4 2022$435,609
+49.2%
45,376
+25.8%
0.00%
Q3 2022$292,000
+29.8%
36,062
-10.6%
0.00%
Q2 2022$225,000
-19.9%
40,341
-19.6%
0.00%
Q1 2022$281,000
+56.1%
50,180
+22.4%
0.00%
Q4 2021$180,000
-53.4%
41,009
+0.1%
0.00%
Q3 2021$386,000
+22.2%
40,983
-5.6%
0.00%
Q2 2021$316,000
+23.9%
43,430
+6.0%
0.00%
Q1 2021$255,000
-40.8%
40,977
-29.4%
0.00%
Q4 2020$431,000
+62.0%
58,029
+32.4%
0.00%
Q3 2020$266,000
+40.0%
43,823
+92.6%
0.00%
Q2 2020$190,000
+6233.3%
22,753
+5588.2%
0.00%
Q4 2019$3,000400
+39900.0%
0.00%
Q3 2019$0
-100.0%
1
-99.3%
0.00%
Q2 2019$1,000
-94.1%
142
-96.0%
0.00%
Q1 2019$17,000
-88.0%
3,535
-84.1%
0.00%
Q4 2018$142,000
-27.6%
22,186
-7.5%
0.00%
Q3 2018$196,000
-28.7%
23,988
-8.8%
0.00%
Q2 2018$275,000
+1095.7%
26,305
+1309.7%
0.00%
Q1 2018$23,000
+475.0%
1,866
+409.8%
0.00%
Q4 2017$4,0003660.00%
Other shareholders
FENNEC PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 2,433,230$18,128,0008.76%
Solas Capital Management, LLC 800,000$5,960,0004.55%
Southpoint Capital Advisors LP 4,077,214$30,375,0000.53%
683 Capital Management, LLC 1,110,000$8,269,0000.39%
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV 40,000$298,0000.26%
Avoro Capital Advisors LLC 1,670,000$12,442,0000.21%
Eventide Asset Management 1,120,000$8,344,0000.13%
Hartford Financial Management Inc. 38,848$289,0000.08%
Granahan Investment Management 394,810$2,941,0000.07%
Planned Solutions, Inc. 800$6,0000.01%
View complete list of FENNEC PHARMACEUTICALS INC shareholders